1 Min Read
March 1 (Reuters) - Pdl Biopharma Inc
* Pdl biopharma inc- company’s board of directors has authorized repurchase of up to $30 million of company’s common stock through march 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.